This volume focuses on therapeutic targets that were identified after TNF blockade. All these targets have recently been registered or are currently under development for the treatment of rheumatoid arthritis. Each chapter explores the biological rationale of a distinct therapeutic target in great detail. Readers will discover the latest in vitro work, animal models, and results from clinical trials.
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
This volume focuses on therapeutic targets that were identified after TNF blockade. All these targets have recently been registered or are currently under development for the treatment of rheumatoid arthritis. Each chapter explores the biological rationale of a distinct therapeutic target in great detail. Readers will discover the latest in vitro work, animal models, and results from clinical trials.
Imprint | Birkhauser Verlag AG |
Country of origin | Switzerland |
Series | Progress in Inflammation Research |
Release date | March 2009 |
Availability | Expected to ship within 12 - 17 working days |
First published | March 2009 |
Editors | Paul-Peter Tak |
Dimensions | 244 x 170 x 18mm (L x W x T) |
Format | Hardcover |
Pages | 228 |
Edition | 2009 ed. |
ISBN-13 | 978-3-7643-8237-7 |
Barcode | 9783764382377 |
Categories | |
LSN | 3-7643-8237-6 |